Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data.
Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data.
复制标题
抑郁孕妇的药物治疗：克服收集基本数据的障碍。
DOI：
10.1038/clpt.2009.160
复制
发表时间：
2009
影响因子：
6.7
通讯作者：
Goldkind,SF
中科院分区：
文献类型：
--
作者：
Wisner,KL;Appelbaum,PS;Uhl,K;Goldkind,SF
大约3%的孕妇服用抗抑郁药物。关于抗抑郁药物对短期和长期母子结局的影响的信息是非常可取的，但被忽视了。对于参与医学研究的怀孕受试者来说，治疗信息的匮乏比风险更令人担忧的立场正在得到支持。强制要求收集暴露在生育中的妇女的生殖结果数据，这是对我们最脆弱的成员承担社会责任的迟来的一步。《临床药理学与治疗学》(2009)864,362-365。DOI：10.1038/clpt.2009.160
Approximately 3% of pregnant women take antidepressant medications. Information on the impact of antidepressants on short‐ and long‐term maternal and offspring outcomes is highly desirable but neglected. The position that the dearth of treatment information is of greater concern than the risks to pregnant subjects involved in medical research is gaining support. Mandating the collection of reproductive outcome data in exposed childbearing women is an overdue step toward societal responsibility to our most vulnerable members.Clinical Pharmacology & Therapeutics(2009)864, 362–365. doi:10.1038/clpt.2009.160